Lymphatic absorption of α-linolenic acid in rats fed flaxseed oil-based emulsion.

Université Bordeaux 1, Laboratoire CBMN UMR 5248, Talence Cedex, France.
The British journal of nutrition (Impact Factor: 3.45). 11/2010; 105(7):1026-35. DOI: 10.1017/S000711451000454X
Source: PubMed

ABSTRACT The bioavailability of α-linolenic acid (ALA) from flaxseed oil in an emulsified form v. a non-emulsified form was investigated by using two complementary approaches: the first one dealt with the characterisation of the flaxseed oil emulsion in in vitro gastrointestinal-like conditions; the second one compared the intestinal absorption of ALA in rats fed the two forms of the oil. The in vitro study on emulsified flaxseed oil showed that decreasing the pH from 7·3 to 1·5 at the physiological temperature (37°C) induced instantaneous oil globule coalescence. Some phase separation was observed under acidic conditions that vanished after further neutralisation. The lecithin used to stabilise the emulsions inhibited TAG hydrolysis by pancreatic lipase. In contrast, lipid solubilisation by bile salts (after lipase and phospholipase hydrolysis) was favoured by preliminary oil emulsification. The in vivo absorption of ALA in thoracic lymph duct-cannulated rats fed flaxseed oil, emulsified or non-emulsified, was quantified. Oil emulsification significantly favoured the rate and extent of ALA recovery as measured by the maximum ALA concentration in the lymph (Cmax = 14 mg/ml at 3 h in the emulsion group v. 9 mg/ml at 5 h in the oil group; P < 0·05). Likewise, the area under the curve of the kinetics was significantly higher in the emulsion group (48 mg × h/ml for rats fed emulsion v. 26 mg × h/ml for rats fed oil; P < 0·05). On the whole, ALA bioavailability was improved with flaxseed oil ingested in an emulsified state. Data obtained from the in vitro studies helped to partly interpret the physiological results.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The present work was designed to prepare linseed oil (LSO) microemulsion and explore the possibility of enhancing the uptake and utilization of α-linolenic acid (ALA) present in LSO. The bioavailability of encapsulated LSO as against native oil was monitored in rats by measuring the uptake in vitro using the intestinal everted sac model and in-vivo administration of microemulsions of LSO to rats for a period of 30 days. Microemulsions were prepared by using different binding materials such as gum acacia, whey protein and lipoid. When LSO was encapsulated with gum acacia, whey protein and lipoid, the levels of ALA uptake into intestinal sacs was increased by 6, 17 and 28 % as compared to oil given without encapsulation. EPA and DHA were not observed in the oil absorbed by intestinal everted sacs when given as emulsions with gum acacia or whey protein. When LSO was given as microemulsions with lipoid, EPA + DHA was observed in oil absorbed by intestinal sacs. Similarly when LSO was given as a lipoid emulsion by intubation to rats, the EPA and DHA in serum lipids were found to be 41 and 34 μg/ml, respectively while rats given LSO without encapsulation contained EPA and DHA at 9.1 and 8.8 μg/ml, respectively. Similar changes in omega-3 fatty acid content in liver lipids were observed when LSO was given as a microemulsion with lipoid. This study indicated that ALA was taken up and metabolized to long chain omega-3 PUFA when given as microemulsion with lipoid.
    Lipids 10/2012; · 2.56 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to quantitatively clarify the effect of alky-chain length of a triglyceride in an emulsion on the partitioning of highly lipophilic compounds into the lymph fluid after their oral administration. Highly lipophilic anthraquinone derivatives were orally administered in emulsions to rats. Emulsions composed of long-, medium-, and short-chain triglycerides (LCT, MCT, and SCT emulsions, respectively) were used. The concentrations of the compounds in plasma and lymph fluid were periodically determined and their partitioning to the lymph was calculated using a mathematical model. Intestinal absorption of all compounds was enhanced and the plasma concentrations of the compounds were found to be in the following order: LCT emulsion > MCT emulsion > SCT emulsion. The amounts of each compound recovered in the lymph were not in agreement with their lipophilicity. Quantitative analysis revealed that the partitioning of the compounds to the lymph may be determined by the solubility of the compound in the triglyceride in the form of an emulsion and the amount of triglyceride transferred to the lymph fluid. These results suggest a possibility that the amount of a compound absorbed via the lymph route after oral administration can be quantitatively controlled by the formulations.
    Archives of Pharmacal Research 10/2013; · 1.54 Impact Factor

Full-text (2 Sources)

Available from
May 20, 2014